Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest of CRESCENT BIOPHARMA, INC. from 30 Jun 2013 to 31 Dec 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.
Summary
CRESCENT BIOPHARMA, INC. annual and quarterly Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest in USD history and change rate from 30 Jun 2013 to 31 Dec 2025.
  • CRESCENT BIOPHARMA, INC. Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest for the quarter ending 31 Dec 2024 was $17,867,000.
Source SEC data
View on sec.gov
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest, Annual (USD)
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest, Quarterly (USD)
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest, YoY Quarterly Change (%)

CRESCENT BIOPHARMA, INC. Annual Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2025 $151,942,000 01 Jan 2025 31 Dec 2025 10-K 26 Feb 2026 2025 FY

CRESCENT BIOPHARMA, INC. Quarterly Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q4 2024 $17,867,000 20 Sep 2024 31 Dec 2024 10-K 26 Feb 2026 2025 FY
Q3 2015 $7,168,071 -$473,736 -7.1% 01 Jul 2015 30 Sep 2015 10-Q 12 Nov 2015 2015 Q3
Q2 2015 $10,389,405 +$2,320,926 +29% 01 Apr 2015 30 Jun 2015 10-Q 06 Aug 2015 2015 Q2
Q3 2014 $6,694,335 -$2,993,450 -81% 01 Jul 2014 30 Sep 2014 10-Q 12 Nov 2015 2015 Q3
Q2 2014 $8,068,479 +$11,565,539 01 Apr 2014 30 Jun 2014 10-Q 06 Aug 2015 2015 Q2
Q3 2013 $3,700,885 01 Jul 2013 30 Sep 2013 10-Q 31 Oct 2014 2014 Q3
Q2 2013 $3,497,060 01 Apr 2013 30 Jun 2013 10-Q 31 Jul 2014 2014 Q2
* An asterisk sign (*) next to the value indicates that the value is likely invalid.